GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Other Stockholders Equity

Yumanity Therapeutics (FRA:8IY) Other Stockholders Equity : €0.00 Mil (As of Sep. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Other Stockholders Equity?

Yumanity Therapeutics's Other Stockholders Equity for the quarter that ended in Sep. 2022 was €0.00 Mil.

Yumanity Therapeutics's quarterly Other Stockholders Equity increased from Mar. 2022 (€-0.00 Mil) to Jun. 2022 (€0.00 Mil) but then declined from Jun. 2022 (€0.00 Mil) to Sep. 2022 (€0.00 Mil).

Yumanity Therapeutics's annual Other Stockholders Equity stayed the same from Dec. 2019 (€0.00 Mil) to Dec. 2020 (€0.00 Mil) but then increased from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€0.00 Mil).


Yumanity Therapeutics Other Stockholders Equity Historical Data

The historical data trend for Yumanity Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Other Stockholders Equity Chart

Yumanity Therapeutics Annual Data
Trend Dec19 Dec20 Dec21
Other Stockholders Equity
- - -

Yumanity Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Yumanity Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Yumanity Therapeutics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Yumanity Therapeutics (FRA:8IY) Business Description

Traded in Other Exchanges
N/A
Address
40 Guest Street, Suite 4410, Boston, MA, USA, 02135
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines